PENTAPHARMA
Board
2 directors, last change in 2025Director
appointed by deed of 25-07-2025
term without a fixed end
listed in the 2025 annual accounts, filed on 13-07-2026
UNIPHARM
Director, permanent representative VANDENBERGHE Chris
appointed by deed of 25-07-2025
term without a fixed end
listed in the 2025 annual accounts, filed on 13-07-2026
Permanent representatives 1
Mandates through the years
2 names, the dashed line is todayTRYPSTEEN Kristiaan
Director
Director
UNIPHARM
Director
Director
Board
Mandates as a list
- TRYPSTEEN Kristiaan
- Director, from 14-11-2016 to date
- UNIPHARM
- Director, from 14-11-2016 to date
Control
Shareholder
Equity €369,364
Profit €16,816 in 2025 (loss €55,588 in 2024)
Checked score 89
Source: accounts UNIPHARM 2025
20%
This company
PENTAPHARMA
Equity €38,418
Profit €2,769 in 2025
Capital
- Contribution
- €20,000
- Source
- deed of 25-07-2025
Owners through the years
as the annual accounts name themOwners as a list
- UNIPHARM
Source: lists of holdings in the owners' accounts
Capital transactions
Capital over time
- 25-07-2025 Converted to unavailable equity · €20,000
- 25-07-2025 Converted to available equity